Drug-related problems: Evaluation of a classification system in the daily practice of a Swiss University Hospital

Pharmacy World and Science

Volumn 30, Issue 6, 2008, Pages 768-776

  Lampert, Markus L ^a   Kraehenbuehl, Stephan ^b   Hug, Balthasar L ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adverse drug events; Adverse drug reactions; Classification systems; Clinical pharmacist; Cost; Drug related problems; Hospital care; PCNE DRP classification; Pharmaceutical interventions; Switzerland

Indexed keywords

AMANTADINE; AMYLASE; FLUOROURACIL; IRBESARTAN; ISONIAZID; PIPERACILLIN PLUS TAZOBACTAM; PROTEINASE; PYRAZINAMIDE; RIFAMPICIN; TAMSULOSIN; TRIACYLGLYCEROL LIPASE;

ARTICLE; CLINICAL EVALUATION; CLINICAL PRACTICE; CONFUSION; DRUG BLOOD LEVEL; DRUG COST; DRUG INDUCED DISEASE; DRUG OVERDOSE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL STAFF; PHARMACEUTICAL CARE; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTITUDE OF HEALTH PERSONNEL; COSTS AND COST ANALYSIS; DRUG COSTS; HOSPITALS, UNIVERSITY; HUMANS; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; PROSPECTIVE STUDIES; SWITZERLAND;

EID: 56549094831     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-008-9213-8     Document Type: Article

References (23)

1. A Krähenbühl-Melcher R Schlienger M Lampert M Haschke J Drewe S Krähenbühl 2007 Drug related problems in hospitals-a review of the recent literature Drug Saf 30 379 407
2. RG Schlienger TF Luescher RA Schoenenberger WE Haefeli 1999 Academic detailing improves identification and reporting of adverse drug events Pharm World Sci 3 110 5
3. AJ Forster HJ Murff JF Peterson TK Gandhi DW Bates 2003 The incidence and severity of adverse events affecting patients after discharge from the hospital Ann Intern Med 138 161 7
4. PJ Kaboli AB Hoth BJ McClimon JL Schnipper 2006 Clinical pharmacists and inpatient medical care-a systematic review Arch Intern Med 166 955 64
5. GT Schumock MG Butler PD Meek LC Vermeulen BV Arondekar JL Bauman 2003 2002 Task force on economic evaluation of clinical pharmacy services of the American College of Clinical Pharmacy Pharmacotherapy 23 113 32
6. RE Ferner JK Aronson 2006 Clarification of terminology in medication errors Drug Saf 29 1011 22
7. Pharmaceutical Care Network Europe. PCNE Classification for Drug-related Problems V5.00. 2005. www.pcne.org/dokumenter/PCNE%20classificationV5.00.pdf (download 02-05-2005).
8. JK Aronson 2006 A prescription for better prescribing Br J Clin Pharmacol 61 487 91
9. F Van Mil T Westerlund KE Hersberger MA Schaefer 2004 Drug-related problem classification systems Ann Pharmacother 38 859 67
10. B Allenet P Bedouch FX Rose 2006 Validation of an instrument for the documentation of clinical pharmacists' interventions Pharm World Sci 28 181 8
11. SM AbuRuz NR Bulatova AM Yousef 2006 Validation of a comprehensive classification tool for treatment related problems Pharm Word Sci 28 222 32
12. M Schaefer 2002 Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc Pharm World Sci 24 120 7
13. Lagler M, editor. Arzneimittelkompendium der Schweiz. 2007. 28th ed. (ISBN 3-85640-313-2), Basel: Documed; 2006.
14. HT Hatoum RA Hutchinson LR Elliott DL Kendzierski 1988 Physicians' review of significant interventions by clinical pharmacists in inpatient care Drug Intell Clin Pharm 22 980 2
15. MJ Dooley KM Allen CJ Doecke 2004 A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals Br J Clin Pharm 57 513 21
16. JM Overhage A Lukes 1999 Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities Am J Health Syst Pharm 56 2444 50
17. Ganso M. Documentation and analysis of pharmaceutical interventions, 6. Konstanzer Apothekerkolloquium. 2006. (Oral Communication).
18. JD Klopfer TR Einarson 1990 Acceptance of pharmacists' suggestions by prescribers: a literature review Hosp Pharm 25 830 6
19. LL Leape DJ Cullen MD Clapp 1999 Pharmacist participation on physician rounds and adverse drug events in the intensive care unit JAMA 282 267 70
20. ST McMullin JA Hennenfelt TC Bailey 1999 A prospective, randomized trial to assess the cost of pharmacist-initiated interventions Arch Int Med 159 2306 9
21. T Croft Buck L Brandstru I Brandslund JP Kampmann 2007 The effects of introducing a clinical pharmacist on orthopaedic wards in Denmark Pharm World Sci 29 12 8
22. S Ruettimann B Keck C Hartmeier A Maetzel HC Bucher 2004 Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital Clin Infect Dis 38 348 56
23. J Bajcar T Chin W Chui K Wichman 1995 Development of a comprehensive clinical pharmacy workload documentation system Can J Hosp Pharm 48 80 9